Symbol
Cardiff Oncology, Inc.
Full name of the company.
MEDICAL-BIOMED/GENETICS
Industry name
DRUGS
Major industry name
Medical
Sector name
$2.75
Current price of the stock
$2M
Trading volume of the stock
$128.9M
Market capitalization of the company
Micro Cap
Category of market capitalization
-
Long-term growth mean estimate
5.00
Mean analyst rating
324.22%
Potential price appreciation based on analyst price targets
-
Percentage difference of EPS surprise
-
Dividend change over 1 year
$0.00
Shows the amount of dividend paid
-
Total debt to total equity ratio
4.74
Current ratio
100.00%
Gross profit margin
-7636.97%
Operating profit margin
-7636.97%
Earnings before interest and taxes (EBIT) margin
-
Earnings before interest, taxes, depreciation, and amortization (EBITDA) margin
-7184.85%
Pretax profit margin
-7188.48%
Net profit margin
-24.00%
Measures profitability relative to shareholders' equity
-24.00%
ROE excluding intangible assets
-18.85%
Measures profitability relative to total assets
-24.00%
Measures profitability relative to invested capital
0.00
Asset turnover ratio
-
Inventory turnover ratio
0.27
Receivables turnover ratio
337.09
Average number of days it takes to collect receivables
-2.93
Measures valuation relative to earnings
-
P/E based on future earnings estimates
187.05
Measures valuation relative to sales
2.71
Measures valuation relative to book value
-1.50
Measures valuation relative to operating cash flow
-1.49
Measures valuation relative to free cash flow
0
Indicates company's M&A activity
© 2022 - 2025 QuantStrategy.io, Arizet Labs, LLC
